Company news
Avalo Therapeutics, Inc. news in 2023
Avalo Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
December 26, 2023
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
December 6, 2023
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 8, 2023
Avalo Completes Divestiture of AVTX-800 Series
October 30, 2023
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation
September 25, 2023
Avalo Enters into Agreement to Divest AVTX-800 Series
September 11, 2023
Avalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 5, 2023
Avalo Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 2, 2023
Avalo to Participate in SVB Securities Therapeutics Forum
July 5, 2023
Avalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic Asthma
June 25, 2023
Avalo to Present at the Jefferies Healthcare Conference
May 31, 2023
Avalo Announces Appointment of Michael Croft, Ph.D. and Jeff Edelson, M.D. to its Scientific Advisory Board
May 21, 2023
Avalo to Present at ATS 2023 Respiratory Innovation Summit
May 14, 2023
Avalo to Present at the 2023 RBC Capital Markets Global Healthcare Conference
May 9, 2023
Avalo Reports First Quarter 2023 Financial Results and Provides Business Updates
May 3, 2023
Avalo Reports 2022 Financial Results and Provides Business Updates
March 28, 2023
Avalo to Present at Oppenheimer's 33rd Annual Healthcare Conference
March 6, 2023
Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants
February 1, 2023
Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants
February 1, 2023
Avalo Announces it Has Completed Targeted Enrollment of 80 Patients in Phase 2 PEAK Trial of AVTX-002 in Non-Eosinophilic Asthma
January 16, 2023
Decks in 2023
- Investor Presentation (September 2023)
Investor deck · 26 slides · Sep 11, 2023
- Investor Presentation (July 2023)
Investor deck · 29 slides · Jul 21, 2023
- Investor Presentation (March 2023)
Investor deck · 32 slides · Mar 13, 2023
- Investor Presentation (January 2023)
Investor deck · 32 slides · Jan 17, 2023